Annual Current Assets
$8.05 M
+$2.02 M+33.63%
31 December 2023
Summary:
BioNexus Gene Lab annual total current assets is currently $8.05 million, with the most recent change of +$2.02 million (+33.63%) on 31 December 2023. During the last 3 years, it has risen by +$896.90 thousand (+12.54%). BGLC annual current assets is now at all-time high.BGLC Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$7.04 M
-$803.40 K-10.24%
30 September 2024
Summary:
BioNexus Gene Lab quarterly total current assets is currently $7.04 million, with the most recent change of -$803.40 thousand (-10.24%) on 30 September 2024. Over the past year, it has dropped by -$1.01 million (-12.52%). BGLC quarterly current assets is now -14.88% below its all-time high of $8.27 million, reached on 30 September 2023.BGLC Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BGLC Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -12.5% |
| 3 y3 years | +12.5% | -1.5% |
| 5 y5 years | +811.7% | +697.6% |
BGLC Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +33.6% | -14.9% | +34.7% |
| 5 y | 5 years | at high | +811.7% | -14.9% | +877.4% |
| alltime | all time | at high | +811.7% | -14.9% | +877.4% |
BioNexus Gene Lab Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.04 M(-10.2%) |
| June 2024 | - | $7.84 M(-0.8%) |
| Mar 2024 | - | $7.91 M(-1.8%) |
| Dec 2023 | $3.35 M(+23.3%) | $8.05 M(-2.7%) |
| Sept 2023 | - | $8.27 M(+58.2%) |
| June 2023 | - | $5.23 M(-4.3%) |
| Mar 2023 | - | $5.46 M(-9.3%) |
| Dec 2022 | $2.72 M(+12.1%) | $6.02 M(+11.3%) |
| Sept 2022 | - | $5.41 M(-6.2%) |
| June 2022 | - | $5.77 M(-12.6%) |
| Mar 2022 | - | $6.60 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $2.42 M(+13.8%) | - |
| Dec 2021 | - | $7.15 M(-3.4%) |
| Sept 2021 | - | $7.40 M(+4.3%) |
| June 2021 | - | $7.10 M(-6.1%) |
| Mar 2021 | - | $7.56 M(-5.3%) |
| Dec 2020 | $2.13 M(+510.8%) | $7.99 M(+1008.8%) |
| Sept 2020 | - | $720.20 K(-5.6%) |
| June 2020 | - | $762.80 K(-5.6%) |
| Mar 2020 | - | $808.10 K(-8.4%) |
| Dec 2019 | $348.70 K(-1.5%) | $882.60 K |
| Dec 2018 | $353.90 K | - |
FAQ
- What is BioNexus Gene Lab annual total current assets?
- What is the all time high annual current assets for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly total current assets?
- What is the all time high quarterly current assets for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly current assets year-on-year change?
What is BioNexus Gene Lab annual total current assets?
The current annual current assets of BGLC is $8.05 M
What is the all time high annual current assets for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual total current assets is $8.05 M
What is BioNexus Gene Lab quarterly total current assets?
The current quarterly current assets of BGLC is $7.04 M
What is the all time high quarterly current assets for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly total current assets is $8.27 M
What is BioNexus Gene Lab quarterly current assets year-on-year change?
Over the past year, BGLC quarterly total current assets has changed by -$1.01 M (-12.52%)